Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Houston TX, Orange City FL, Toledo OH, Grand Rapids MI,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06095583

Phase3, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX, New Orleans LA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

for
Peripheral T/NK Cell Lymphoma (R/R PTCL)
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05274997

Phase2, Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

for
Malignant Solid Neoplasm
Location: Houston TX, Edinburg TX, Birmingham AL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642611

Phase3, Recruiting
Featured

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

for
Irritable Bowel Syndrome
Location: Houston TX, Hot Springs AR, Little Rock AR, Atlanta GA,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT03339128

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Bellaire TX, Webster TX, Fountain Valley CA,
Sponsor: Oneness Biotech Co., Ltd.

Sex: All

Age: 18 - 65

Code: NCT06397911

Phase2, Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

for
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 65

Code: NCT02115295

Phase2, Recruiting

Mapping of Human Cognition

for
Epilepsy, Brain Tumor
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18 - 70+

Code: NCT05989893

Recruiting

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06036810

Recruiting

Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies

for
Brain Malignancies, Pseudoprogression
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06199479

Phase1, Recruiting

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

for
Metastatic Malignant Neoplasm
Location: Houston TX, San Antonio TX, Fairfax VA, Baltimore MD,
Sponsor: NextPoint Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06240728

Phase1, Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Houston TX, Nashville TN, Denver CO, Tampa FL,
Sponsor: Nested Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06326411

Phase1, Recruiting

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

for
Multiple Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT05776979

Phase2, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Houston TX, Shreveport LA, Birmingham AL, Atlanta GA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase3, Recruiting

A Multi Center Study of Sexual Toxicities After Radiotherapy

for
Malignant Neoplasms
Location: Houston TX, Atlanta GA, New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Female

Age: 18+

Code: NCT05394428

Recruiting

Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies

for
Cancer
Location: Houston TX, San Antonio TX, Louisville KY,
Sponsor: Advanced Cancer Therapeutics

Sex: All

Age: 18+

Code: NCT02044861

Phase1, Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

for
Myeloid Leukemia, Philadelphia Positive
Location: Houston TX, Jackson MS, Indianapolis IN, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 17

Code: NCT04925479

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: Houston TX, San Antonio TX, Dothan AL, Kansas City MO,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase2, Recruiting

Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix

for
Cervical Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 0+

Code: NCT01606293

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Houston TX, Nashville TN, Jacksonville FL, Denver CO,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase1, Phase2, Recruiting